(Q43836354)

English

Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting

scientific article published in January 1991

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

phase II clinical trial

0 references

phase I clinical trial

0 references

author name string

D M Shin

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Y Holoye

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

W K Murphy

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A Forman

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S C Papasozomenos

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

W K Hong

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Raber

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

145-149

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of didemnin B, a depsipeptide from the sea

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and cellular effects of didemnins A and B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of didemnin B in the human tumor stem cell assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Didemnins: Antiviral and Antitumor Depsipeptides from a Caribbean Tunicate

1 reference

https://pubmed.ncbi.nlm.nih.gov/1662119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00687325

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43836354&oldid=2206285106"